Hiroshi Furusho
Overview
Explore the profile of Hiroshi Furusho including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
58
Citations
375
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Miwa K, Minamikawa R, Iida O, Furusho H, Yasuda T
Eur Heart J Case Rep
. 2024 Dec;
8(12):ytae631.
PMID: 39659474
Background: Drug-eluting therapies remarkably reduce the incidence of restenosis and have revolutionized endovascular strategies for femoropopliteal lesions in patients with peripheral artery disease, nevertheless, concerns have arisen over the risk...
2.
Nakagawa Y, Hayashi K, Tada T, Asakawa M, Yoshida S, Nomura A, et al.
Intern Med
. 2024 Aug;
PMID: 39111889
Danon disease (DD) is a rare lysosomal storage disorder resulting from pathogenic variants of the lysosome-associated membrane protein type 2 (LAMP-2) gene. The disease is characterized by severe cardiomyopathy, which...
3.
Cui S, Hayashi K, Kobayashi I, Hosomichi K, Nomura A, Teramoto R, et al.
J Mol Cell Cardiol
. 2023 Mar;
177:50-61.
PMID: 36898499
Genetic testing for inherited arrhythmias and discriminating pathogenic or benign variants from variants of unknown significance (VUS) is essential for gene-based medicine. KCNQ1 is a causative gene of type 1...
4.
Nakagawa Y, Furusho H, Miwa K, Yasuda T
HeartRhythm Case Rep
. 2023 Jan;
9(1):38-42.
PMID: 36685677
No abstract available.
5.
Hayashi K, Tanaka Y, Tsuda T, Nomura A, Fujino N, Furusho H, et al.
Heart Vessels
. 2022 Dec;
38(3):412.
PMID: 36508013
No abstract available.
6.
Hayashi K, Tanaka Y, Tsuda T, Nomura A, Fujino N, Furusho H, et al.
Heart Vessels
. 2022 Oct;
38(3):402-411.
PMID: 36251049
Evidence suggests that atrial fibrillation (AF) could increase the risk of worsening kidney function (WKF) which is linked to an increased risk of stroke, bleeding, and death in AF patients....
7.
Nakagawa Y, Furusho H, Kamiya Y, Nishikawa R, Miwa K, Yasuda T
J Cardiol Cases
. 2022 May;
25(5):275-278.
PMID: 35582067
Takotsubo cardiomyopathy (TCM) is a transient acute cardiac disorder often associated with QT prolongation, but this rarely leads to torsades de pointes (TdP). Additionally, it is a rare complication of...
8.
Hirai T, Miwa K, Furusho H, Yasuda T
Eur Heart J Case Rep
. 2022 Feb;
6(1):ytab505.
PMID: 35106439
Background: Although rare, angiosarcoma is the most common type of cardiac primary malignancy. This disease can cause life-threatening complications and the prognosis remains poor. There is no standard approach to...
9.
Usuda K, Kato T, Tsuda T, Tada H, Niwa S, Usui S, et al.
Heart Vessels
. 2021 Sep;
37(2):327-336.
PMID: 34524497
The impact of catheter ablation for atrial fibrillation (AF) on cardiovascular events and mortality is controversial. We investigated the impact of sinus rhythm maintenance on major adverse cardiac and cerebrovascular...
10.
Terakami T, Nagaya S, Hayashi K, Furusho H, Fujino N, Kato T, et al.
J Atheroscler Thromb
. 2021 Aug;
29(7):1059-1068.
PMID: 34334529
Aims: Measurement of protein S (PS) activity in patients taking direct oral anticoagulants (DOACs) using reagents based on a clotting assay results in falsely high PS activity, thus masking inherited...